The independent source for health policy research, polling, and news.
41 - 60 of 382 Results
Millions of dollars from national opioid settlements are pouring into Mississippi. The state and localities haven’t spent much yet. In many cases, how the money will be used is up in the air.
KFF Health News gives readers a chance to comment on a recent batch of stories.
Details about where the machines would go — and how they would help those most at risk — are sparse. The state has proposed using them to distribute naloxone and fentanyl testing strips.
KFF Health News and California Healthline staff made the rounds on national and local media in recent weeks to discuss topical stories. Here’s a collection of their appearances.
California is in line for more than $4 billion in opioid settlement funds, and local governments are most often spending the first tranche of money on lifesaving drugs. An exclusive KFF Health News analysis also found projects to help police deter youths’ drug use and counsel officers who witness overdoses.
A popular scale for measuring pain doesn’t work, but medicine still has no better alternative.
KFF Health News and California Healthline staff hit the airwaves in the last couple of weeks to discuss stories in the headlines. Here’s a collection of their appearances.
In what will certainly be remembered as a landmark decision, the Supreme Court has overruled a 40-year-old precedent that gave federal agencies, rather than judges, the power to interpret ambiguous laws passed by Congress. Administrative experts say the decision will dramatically change the way key health agencies do business. Also, the court decided not to decide whether a federal law requiring hospitals to provide emergency care overrides Idaho’s near-total ban on abortion. Alice Miranda Ollstein of Politico, Victoria Knight of Axios, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
The court struck down a $6 billion bankruptcy plan from Purdue Pharma, the maker of OxyContin. What does this mean? We’ll explain.
KFF Health News gives readers a chance to comment on a recent batch of stories.
KFF Health News and California Healthline staffers made the rounds on national and local media in the last couple of weeks to discuss topical stories. Here’s a collection of their appearances.
As billions of dollars from settlements with opioid manufacturers and distributors go to state and local governments, efforts to reduce the epidemic’s harm can be hamstrung by drug paraphernalia laws. Health authorities say distributing clean syringes to users can save lives, but in states like Pennsylvania, it may be illegal.
A recent broadcast of “Last Week Tonight With John Oliver” frequently cited KFF Health News in its examination of how billions of dollars from the opioid settlements are being spent.
Hundreds of Native American tribes are getting money from settlements with companies that made or sold prescription painkillers. Some are investing it in sweat lodges, statistical models, and insurance-billing staffers.
KFF Health News and California Healthline staff made the rounds on national and local media over the past two weeks to discuss recent stories. Here’s a collection of their appearances.
Facing widening racial disparities in overdose deaths, Philadelphia officials are sending workers and volunteers to knock on doors across the city, aiming to equip households with naloxone and other drug overdose prevention supplies. City officials hope a proactive approach will normalize naloxone as an everyday item in people’s medicine cabinets and prevent overdoses, especially among Black residents.
The national opioid settlements don’t prohibit using money for initiatives already supported by other means, but doing so could dilute the impact.
For years, addiction response teams have traveled around Florida to connect people who have overdosed with resources and recovery centers. Now, a handful have a new tool in their kit: buprenorphine, which can help prevent the cravings and withdrawal symptoms that lead to more drug use.
KFF Health News and California Healthline staff made the rounds on national and local media in recent weeks to discuss their stories. Here’s a collection of their appearances.
© 2026 KFF